Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET)

European Journal of Surgical Oncology

Volumn 36, Issue 2, 2010, Pages 189-194

  Servois, V ^a   Mariani, P ^a   Malhaire, C ^a   Petras, S ^a   Piperno Neumann, S ^a   Plancher, C ^a   Levy Gabriel, C ^a   Lumbroso le Rouic, L ^a   Desjardins, L ^a   Salmon, R J ^a  

^a INSTITUT CURIE   (France)

Author keywords

Fluorodeoxyglucose positron emission tomography; Liver magnetic resonance imaging; Liver metastase; Uveal melanoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LIVER METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UVEA MELANOMA;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; UVEAL NEOPLASMS;

EID: 74149090998     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.08.010     Document Type: Article

References (22)

1. Vidal J.L., Bacin F., Albuisson E., et al. Epidemiological study of uveal melanoma in France. J Fr Ophtalmol 18 (1995) 520-528
2. Desjardins L., Dorval T., Levy C., et al. Etude randomisée de chimiothérapie adjuvante par le deticène dans le mélanome choroïdien. Ophtalmologie 12 (1998) 168-173
3. Zografos. Tumeurs intraoculaires (2002), Masson p. 212-29
4. Salmon R.J., Levy C., Plancher C., et al. Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. Eur J Surg Oncol 24 (1998) 127-130
5. Mariani P., Piperno-Neumann S., Servois V., et al. Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie. Eur J Surg Oncol 27 (2009) [Epub ahead of print]
6. Semelka R., Martin D., Balci C., and Lance T. Comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 13 (2001) 397-401
7. Premkumar A., Marincola F., Taubenberger J., Chow C., Venzon D., and Schwartzentruher D. Metastatic melanoma: correlation of MRI characteristics and histopathology. J Magn Reson Imaging 1 (1996) 190-194
8. Meli R.J., and Ros P.R. MR appearance of intra-abdominal metastatic melanoma. Magn Reson Imaging 10 (1992) 705-708
9. Holder W., White R., Zuger J., Easton J., and Greene F. Effectiveness of PET for detection of melanoma metastases. Ann Surg 227 (1998) 764-771
10. Ghanem N., Altehoefer C., Högerie S., et al. Detectability of liver metastases in malignant melanoma: prospective comparison of MRI and PET. Eur J Radiol 54 (2005) 264-270
11. Finger P., Kurli M., Reddy S., Tena L., and Pavlick A. Whole body PET/CT for initial staging of choroidal melanoma. Br J Ophthalmol 89 (2005) 1270-1274
12. Kurli M., Reddy S., Tena L., Pavlick A., and Finger P. Whole body PET/CT staging of metastatic choroidal melanoma. Am J Ophthalmol 140 (2005) 193-199
13. Francken A., Fulham M., Millward M., and Thompson J. Detection of metastatic disease in patients with uveal melanoma using PET. Eur J Surg Oncol 32 (2006) 780-784
14. Rappeport E., and Loft A. Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, CT and PET. Abdom Imaging 32 (2007) 624-634
15. Ruers T., Langenhoff B., Neelman N., et al. Value of PET with FDG in patients with colorectal liver metastases: a prospective study. J Clin Oncol 20 (2002) 388-395
16. Fong Y., Saldinger P., Akhurst T., et al. Utility of FDG-PET scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 178 (1999) 282-287
17. Selzner M., Hany T.F., Wildbredt P., Mc Cormack L., Kadry Z., and Clavien P.A. Does the novel PET/CT imaging modality impact on the treatment of patients with colorectal cancer of the liver?. Ann Surg 240 (2004) 1027-1036
18. Rappeport E.D., Loft A., Berthelsen A.K., et al. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation. Acta Radiol 48 (2007) 369-378
19. Lucignani G., Paganeli G., Modorati G., et al. MRI, antibody-guided scintigraphy and glucose metabolism in uveal melanoma. J Comput Assist Tomogr 16 (1992) 77-83
20. Lindholm P., Leskinen S., Nagren K., et al. Carbon11-methionine PET imaging of malignant melanoma. J Nucl Med 36 (1995) 1806-1810
21. Dimitrakopoulou-Strauss A., Strauss L.G., and Burger C. Quantitative PET studies in pretreated melanoma patients: a comparison of 6-(18F)fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis. J Nucl Med 42 (2001) 248-256
22. Ward J., Chen F., Guthrie J., et al. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternate-free response receiver operating characteristic analyses. Radiology 214 (2000) 159-166